The transcription factor PLZF directs the effector program of the NKT cell lineage.

The transcription factor PLZF directs the effector program of the NKT cell lineage.
复制标题

转录因子 PLZF 指导 NKT 细胞谱系的效应程序。

DOI:
10.1016/j.immuni.2008.07.011
复制
发表时间:
2008-09-19
期刊:
影响因子:
32.4
通讯作者:
Bendelac, Albert
Bendelac, Albert
中科院分区:
医学1区
文献类型:
--
作者:
Savage, Adam K.;Constantinides, Michael G.;Han, Jin;Picard, Damien;Martin, Emmanuel;Li, Bofeng;Lantz, Olivier;Bendelac, Albert

文献摘要

参考文献

被引文献

相似文献

CD1D限制性NKT细胞发育的转录控制仍然难以捉摸。 (TH-POK,ZBTB7B)完全特异性地是CD1D限制的NKT细胞和人类MR1特异性MAIT细胞。 NKT细胞前体和PLZF缺陷的NKT细胞无法经历胸膜膨胀和效应子分化,而效应子分化则保留了幼稚的表型,并将其定向到淋巴结。效应子分化并迁移到非淋巴组织。在胸腺发育过程中指导其先天效应子分化。
The transcriptional control of CD1d-restricted NKT cell development has remained elusive. We report that PLZF (promyelocytic leukemia zinc finger; Zbtb16), a member of the BTB/POZ-ZF family of transcription factors which includes the CD4 lineage-specific c-Krox (Th-POK, Zbtb7b), is exquisitely specific to CD1d-restricted NKT cells and human MR1-specific MAIT cells. PLZF was induced immediately after positive selection of NKT cell precursors and PLZF-deficient NKT cells failed to undergo the intrathymic expansion and effector differentiation that characterize their lineage. Instead, they preserved a naïve phenotype and were directed to lymph nodes. Conversely, transgenic expression of PLZF induced CD4 thymocytes to acquire effector differentiation and migrate to non-lymphoid tissues. We suggest that PLZF is a transcriptional signature of NKT cells that directs their innate-like effector differentiation during thymic development.
DOI: 10.1038/nature03338
发表时间: 2005-02-24
期刊: NATURE
影响因子: 64.8
作者:
He, X;He, X;Kappes, DJ
通讯作者: Kappes, DJ
DOI: 10.1038/ni1268
发表时间: 2005-12-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Intlekofer, AM;Takemoto, N;Reiner, SL
通讯作者: Reiner, SL
DOI: 10.1084/jem.191.11.1895
发表时间: 2000-06-05
影响因子: 15.3
作者:
Benlagha, K;Weiss, A;Beavis, A;Teyton, L;Bendelac, A
通讯作者: Bendelac, A
DOI: 10.1084/jem.20050456
发表时间: 2005-08-15
期刊: The Journal of experimental medicine
影响因子: --
作者:
Benlagha K;Wei DG;Veiga J;Teyton L;Bendelac A
通讯作者: Bendelac A
DOI: 10.1016/j.immuni.2005.03.011
发表时间: 2005-06-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Egawa, T;Eberl, G;Littman, DR
通讯作者: Littman, DR